BACE
BACE (β-Secretase) is an aspartic-acid protease that cleaves the amyloid precursor protein (APP) and takes part in the generation of Amyloid β.
Products for BACE
- Cat.No. Product Name Information
- GC14130 AZD3839 AZD3839 is a potent and selective orally active, brain-permeable BACE1 inhibitor (Ki=26 nM). AZD3839 shows 14 and >1000-fold selectivity against BACE2 and cathepsin D, respectively. AZD3839 exhibits dose- and time-dependent lowering of plasma, brain, and cerebrospinal fluid Aβ levels in mouse, guinea pig, and non-human primate. AZD3839 can be used for the research of Alzheimer's disease.
- GC15715 AZD3839 BACE1 inhibitor,potent and selective
- GC17227 LY2886721 BACE inhibitor
- GC11098 Verubecestat (MK-8931) Verubecestat (MK-8931) (MK-8931) is an orally active, high-affinity BACE1 and BACE2 inhibitor with Ki values of 2.2 nM and 0.38 nM.
- GC26035 Verubecestat (MK-8931) Trifluoroacetate Verubecestat (MK-8931) Trifluoroacetate is a potent and selective beta-secretase inhibitor and BACE1 protein inhibitor or Beta-site APP-cleaving enzyme 1 inhibitor.